about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor t...
Read More
108.35
-0.84
(-0.77%)
6.3M
XNYS Volume
XNYS 13 Jan, 2026 3:14 PM (EST)
Acquisition Plans
Merck reportedly in talks to acquire cancer-focused biotech company RevMed in a ~$30 bn deal
See details
High Financial Strength
Affordable Valuation
Technically Moderately Bullish
Strong Performer
These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..